cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA368245 | placenta | .a | 2275 to 2633 | 1 to 360 | 360/360 (100 %) | 1 diff (99.8 %id) | |||
AB046820 | brain | .a | 406 to 5806 | 1 to 5401 | tiling clone, available from KIAA, | 5401/5401 (100 %) | 2 diff (100.0 %id) | ||
AI902967 | breast | .b | 994 to 1340 | 347 to 1 | 347/347 (100 %) | 4 diff (98.9 %id) | |||
BC037207 | testis | .b | 6 to 2867 | 1 to 2862 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 2862/2864 (99 %) | 7 diff (99.8 %id) | |
BE004359 | breast_normal | .d | 226 to 507 | 284 to 3 | Submitted on the opposite strand | 282/289 (97 %) | 0 diff (100 %id) | ||
BE720812 | head_neck | .d | 279 to 693 | 422 to 1 | 422/425 (99 %) | 28 diff (93.5 %id) | |||
BF083059 | colon_est | .a | 2433 to 2830 | 1 to 398 | 398/398 (100 %) | 0 diff (100 %id) | |||
BF838816 | head_neck | .b | 1218 to 1780 | 564 to 3 | Submitted on the opposite strand | 562/578 (97 %) | 9 diff (98.5 %id) | ||
BG010610 | placenta_normal | .a | 2702 to 3017 | 330 to 15 | 316/330 (95 %) | 0 diff (100 %id) | |||
BG186039 | .b | 2529 to 2892 | 1 to 364 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 364/364 (100 %) | 8 diff (97.9 %id) | ||
BG201373 | .b | 2528 to 2787 | 1 to 262 | 262/262 (100 %) | 10 diff (96.2 %id) | ||||
DA046664 | bladder | .a | 3371 to 3864 | 2 to 496 | capped | 495/496 (99 %) | 4 diff (99.2 %id) | ||
BQ358886 | head_neck | .b | 683 to 1193 | 18 to 530 | 513/530 (96 %) | 38 diff (92.9 %id) | |||
BQ367426 | placenta_normal | .a | 2685 to 3017 | 346 to 13 | 334/346 (96 %) | 0 diff (100 %id) | |||
DA129935 | alzheimer cortex | .a | 3878 to 4421 | 2 to 546 | capped | 545/545 (100 %) | 2 diff (99.7 %id) | ||
DA160766 | amygdala | .a | 3314 to 3787 | 2 to 475 | capped | 474/474 (100 %) | 2 diff (99.6 %id) | ||
DA168304 | amygdala | .a | 3674 to 4233 | 2 to 562 | capped | 561/561 (100 %) | 2 diff (99.7 %id) | ||
DA174795 | amygdala | .a | 3676 to 4198 | 2 to 524 | capped | 523/523 (100 %) | 0 diff (100 %id) | ||
DA181041 | amygdala | .a | 3647 to 4219 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
DA283018 | corpus callosum | .a | 2728 to 3284 | 2 to 560 | capped | 559/559 (100 %) | 2 diff (99.7 %id) | ||
DA391967 | thalamus | .a | 3263 to 3823 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | ||
BX103928 | placenta | .d | 800 to 1264 | 479 to 15 | AAA | 465/465 (100 %) | 0 diff (100 %id) | ||
Z38969 | brain, total brain | .a | 5480 to 5802 | 323 to 1 | 323/323 (100 %) | 2 diff (99.4 %id) | |||
Z42827 | brain, total brain | .a | 3536 to 3856 | 1 to 321 | 321/321 (100 %) | 1 diff (99.7 %id) | |||
C75513 | .a | 3359 to 3890 | 8 to 540 | 533/544 (97 %) | 4 diff (99.3 %id) | ||||
C75646 | .a | 3359 to 3615 | 8 to 264 | 257/264 (97 %) | 6 diff (97.8 %id) | ||||
CA405601 | adipose | .a | 3650 to 4156 | 1 to 508 | 508/508 (100 %) | 2 diff (99.7 %id) | |||
CB269630 | adipose | .d | 316 to 998 | 15 to 702 | tiling clone, | 688/705 (97 %) | 10 diff (98.6 %id) | ||
CD686397 | normal nasopharynx | .a | 4574 to 5169 | 22 to 617 | 596/617 (96 %) | 6 diff (99.1 %id) | |||
CN348566 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 498 to 1087 | 1 to 591 | 591/591 (100 %) | 1 diff (99.9 %id) | |||
CN348567 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 214 to 659 | 1 to 446 | 446/446 (100 %) | 0 diff (100 %id) | |||
CN371864 | embryonic stem cells, DMSO-treated H9 cellline | .d | 483 to 954 | 8 to 479 | 472/479 (98 %) | 6 diff (98.8 %id) | |||
CN371865 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .d | 807 to 1266 | 1 to 460 | 460/460 (100 %) | 1 diff (99.8 %id) | |||
CR742134 | pooled germ cell tumors | .d | 266 to 754 | 1 to 489 | 489/489 (100 %) | 0 diff (100 %id) | |||
CR933692 | uterus | .a | 281 to 5598 | 1 to 5318 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 5318/5318 (100 %) | 4 diff (100.0 %id) | |
AL530147 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .a | 3310 to 4148 | 1 to 839 | 839/839 (100 %) | 1 diff (99.9 %id) | |||
AL563657 | brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized | .a | 4869 to 5769 | 901 to 1 | 901/901 (100 %) | 6 diff (99.4 %id) | |||
BX431162 | brain, fetal brain | .a | 4387 to 5211 | 1 to 827 | 827/929 (89 %) | 20 diff (97.9 %id) | |||
BX460827 | brain, fetal brain | .a | 3650 to 4534 | 1 to 885 | 885/885 (100 %) | 1 diff (99.9 %id) | |||
CA389358 | eye, RPE/choroid | .b | 1850 to 2468 | 1 to 619 | 619/619 (100 %) | 1 diff (99.9 %id) | |||
CA397285 | eye, RPE/choroid | .b | 1177 to 1827 | 1 to 651 | 651/651 (100 %) | 0 diff (100 %id) | |||
CU454139 | epidermis | .d | 393 to 1023 | 15 to 645 | 631/645 (97 %) | 6 diff (99.1 %id) | |||
CV024837 | mixed | .b | 341 to 982 | 1 to 642 | 642/642 (100 %) | 6 diff (99.1 %id) | |||
DA462577 | cord Blood | .a | 3928 to 4486 | 2 to 561 | capped | 560/560 (100 %) | 1 diff (99.9 %id) | ||
DA477761 | .a | 3322 to 3864 | 2 to 545 | capped | 544/544 (100 %) | 2 diff (99.7 %id) | |||
DB314875 | .a | 5252 to 5802 | 551 to 1 | 551/551 (100 %) | 0 diff (100 %id) | ||||
AL691828 | .a | 2829 to 3352 | 1 to 523 | 523/523 (100 %) | 6 diff (98.9 %id) | ||||
BX489331 | .c | 1 to 679 | 1 to 678 | exact | tiling clone, | 678/678 (100 %) | 2 diff (99.8 %id) | ||
BX495571 | Liver | .b | 713 to 1200 | 1 to 488 | 488/488 (100 %) | 1 diff (99.8 %id) | |||
BX955825 | .b | 270 to 464 | 1 to 195 | 195/196 (99 %) | 0 diff (100 %id) | ||||
DA502050 | brain | .a | 3343 to 3899 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
FN098714 | breast carcinoma | .a | 4029 to 4132 | 1 to 104 | 104/104 (100 %) | 0 diff (100 %id) | |||
FN106312 | breast carcinoma | .a | 2507 to 2583 | 1 to 77 | 77/77 (100 %) | 3 diff (96.2 %id) | |||
CD674309 | eye, lens | .a | 4694 to 5131 | 1 to 438 | 438/438 (100 %) | 0 diff (100 %id) | |||
GD157211 | .a | 2943 to 3049 | 1 to 109 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 109/109 (100 %) | 4 diff (96.4 %id) | ||
AW069310 | bone marrow stroma | .b | 1728 to 2083 | 1 to 359 | Submitted on the opposite strand | 359/360 (99 %) | 6 diff (98.4 %id) | ||
DA545427 | .a | 3445 to 3954 | 2 to 511 | capped | 510/510 (100 %) | 0 diff (100 %id) | |||
DA550546 | .a | 3737 to 4275 | 2 to 544 | capped | 543/550 (98 %) | 9 diff (98.4 %id) | |||
BJ992410 | hepatoblastoma | .a | 2509 to 3013 | 505 to 1 | 505/505 (100 %) | 4 diff (99.3 %id) | |||
H92159 | eye, retina | .a | 4617 to 4918 | 1 to 310 | 310/310 (100 %) | 8 diff (97.5 %id) | |||
N32573 | placenta | .d | 387 to 882 | 1 to 498 | Submitted on the opposite strand | 498/498 (100 %) | 4 diff (99.2 %id) | ||
N41913 | placenta | .d | 960 to 1202 | 243 to 1 | Submitted on the opposite strand | 243/243 (100 %) | 1 diff (99.6 %id) | ||
N32594 | placenta | .d | 387 to 922 | 1 to 538 | Submitted on the opposite strand | 538/539 (99 %) | 11 diff (98.0 %id) | ||
N47818 | placenta | .d | 914 to 1202 | 290 to 1 | Submitted on the opposite strand | 290/292 (99 %) | 1 diff (99.7 %id) | ||
N40247 | melanocyte | .a | 2052 to 2561 | 1 to 510 | 510/512 (99 %) | 2 diff (99.7 %id) | |||
N50209 | multiple sclerosis lesions | .a | 4276 to 4445 | 1 to 170 | 170/176 (96 %) | 8 diff (95.5 %id) | |||
AA027359 | heart | .d | 1079 to 1267 | 190 to 2 | 189/190 (99 %) | 0 diff (100 %id) | |||
AA047407 | uterus | .d | 820 to 1264 | 449 to 1 | 449/452 (99 %) | 4 diff (99.2 %id) | |||
AA047527 | uterus | .d | 292 to 463 | 1 to 172 | 172/174 (98 %) | 1 diff (99.5 %id) | |||
AA114885 | uterus | .d | 290 to 767 | 1 to 480 | 480/480 (100 %) | 4 diff (99.2 %id) | |||
AA114886 | uterus | .d | 801 to 1264 | 464 to 1 | 464/464 (100 %) | 1 diff (99.8 %id) | |||
AA151143 | uterus | .d | 291 to 743 | 1 to 463 | fully sequenced, | 463/463 (100 %) | 10 diff (97.9 %id) | ||
AA151144 | uterus | .d | 713 to 1264 | 559 to 1 | fully sequenced, | 559/559 (100 %) | 14 diff (97.5 %id) | ||
AA147626 | uterus | .d | 899 to 1268 | 370 to 1 | fully sequenced, | 370/370 (100 %) | 0 diff (100 %id) | ||
AA147664 | uterus | .d | 507 to 929 | 1 to 424 | fully sequenced, | 424/424 (100 %) | 3 diff (99.3 %id) | ||
AA164842 | .d | 211 to 588 | 1 to 384 | 384/384 (100 %) | 6 diff (98.5 %id) | ||||
AA164843 | .d | 858 to 1267 | 420 to 1 | 420/420 (100 %) | 12 diff (97.2 %id) | ||||
AA425431 | .a | 4511 to 4840 | 10 to 339 | 330/339 (97 %) | 6 diff (98.3 %id) | ||||
AA467841 | .a | 2126 to 2576 | 8 to 454 | 447/454 (98 %) | 7 diff (98.5 %id) | ||||
AA854858 | parathyroid gland, parathyroid tumor | .d | 916 to 1271 | 356 to 1 | 356/356 (100 %) | 2 diff (99.5 %id) | |||
AA860186 | .b | 2379 to 2875 | 497 to 1 | 497/497 (100 %) | 4 diff (99.2 %id) | ||||
AA973025 | pooled | .d | 1 to 469 | 470 to 2 | L14* | tiling clone, | 469/470 (99 %) | 2 diff (99.6 %id) | |
AA969598 | pooled | .f | 1 to 370 | 370 to 1 | exact | tiling clone, | 370/370 (100 %) | 1 diff (99.8 %id) | |
AA970525 | pooled | .d | 862 to 1268 | 406 to 1 | 406/406 (100 %) | 1 diff (99.8 %id) | |||
AA972000 | pooled | .d | 849 to 1179 | 333 to 1 | 333/351 (94 %) | 32 diff (90.9 %id) | |||
AA974002 | pooled germ cell tumors | .d | 1020 to 1264 | 245 to 1 | 245/245 (100 %) | 0 diff (100 %id) | |||
AI017480 | pooled | .d | 3 to 458 | 458 to 3 | tiling clone, | 456/458 (99 %) | 0 diff (100 %id) | ||
AI081772 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .d | 799 to 1264 | 466 to 1 | 466/466 (100 %) | 1 diff (99.8 %id) | |||
AI128047 | uterus | .d | 817 to 1264 | 448 to 1 | 448/448 (100 %) | 1 diff (99.8 %id) | |||
AI129308 | uterus | .d | 909 to 1264 | 356 to 1 | 356/356 (100 %) | 4 diff (98.9 %id) | |||
AI220337 | pooled | .d | 886 to 1266 | 381 to 1 | 381/381 (100 %) | 0 diff (100 %id) | |||
AI221940 | pooled | .d | 1009 to 1272 | 264 to 2 | 263/264 (99 %) | 0 diff (100 %id) | |||
AI301327 | 2 pooled tumors (clear cell type), Kidney | .d | 891 to 1267 | 379 to 3 | 377/379 (99 %) | 0 diff (100 %id) | |||
AI333347 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .d | 822 to 1272 | 452 to 3 | 450/452 (99 %) | 0 diff (100 %id) | |||
AI341910 | pooled germ cell tumors | .a | 3145 to 3499 | 356 to 2 | 355/356 (99 %) | 0 diff (100 %id) | |||
AI370643 | .d | 985 to 1264 | 280 to 1 | 280/280 (100 %) | 0 diff (100 %id) | ||||
AI521900 | Kidney | .d | 889 to 1268 | 402 to 23 | AAA | 380/380 (100 %) | 0 diff (100 %id) | ||
AI522258 | Kidney | .d | 959 to 1267 | 311 to 3 | 309/311 (99 %) | 0 diff (100 %id) | |||
AI491711 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .d | 857 to 1264 | 437 to 31 | AAA | 407/407 (100 %) | 2 diff (99.6 %id) | ||
AI623294 | pooled germ cell tumors | .a | 2930 to 3501 | 572 to 1 | 572/572 (100 %) | 0 diff (100 %id) | |||
AI699552 | pooled germ cell tumors | .d | 1048 to 1264 | 230 to 13 | AAA | 218/218 (100 %) | 2 diff (99.1 %id) | ||
AI620872 | Prostate | .d | 833 to 1268 | 453 to 18 | AAA | 436/436 (100 %) | 1 diff (99.8 %id) | ||
AI669569 | Prostate | .d | 797 to 1264 | 468 to 1 | 468/468 (100 %) | 0 diff (100 %id) | |||
AI761692 | pooled | .d | 701 to 1267 | 570 to 4 | 567/570 (99 %) | 0 diff (100 %id) | |||
AI796284 | Kidney | .a | 4664 to 4992 | 348 to 20 | AAA | 329/329 (100 %) | 3 diff (99.1 %id) | ||
AI885513 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .d | 889 to 1268 | 410 to 30 | AAA | 381/381 (100 %) | 7 diff (98.2 %id) | ||
AW173036 | pooled | .d | 751 to 1272 | 522 to 2 | 521/522 (99 %) | 0 diff (100 %id) | |||
AW236546 | pooled germ cell tumors | .d | 831 to 1264 | 434 to 1 | 434/434 (100 %) | 2 diff (99.6 %id) | |||
AW195178 | Kidney | .d | 905 to 1267 | 365 to 3 | 363/365 (99 %) | 0 diff (100 %id) | |||
AW014410 | .a | 2602 to 3049 | 465 to 18 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 448/448 (100 %) | 2 diff (99.6 %id) | ||
AW450258 | .d | 703 to 1264 | 579 to 18 | AAA | 562/562 (100 %) | 0 diff (100 %id) | |||
AW299379 | Kidney | .a | 2515 to 3049 | 535 to 1 | 535/535 (100 %) | 0 diff (100 %id) | |||
AW439043 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .d | 1058 to 1269 | 212 to 1 | 212/212 (100 %) | 0 diff (100 %id) | |||
AW513016 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .d | 798 to 1264 | 467 to 1 | 467/467 (100 %) | 0 diff (100 %id) | |||
AW594733 | pooled germ cell tumors | .d | 815 to 1264 | 450 to 1 | 450/450 (100 %) | 0 diff (100 %id) | |||
AW772090 | Kidney | .a | 2493 to 3049 | 557 to 1 | 557/560 (99 %) | 0 diff (100 %id) | |||
AW452943 | .d | 797 to 1264 | 485 to 18 | AAA | 468/468 (100 %) | 0 diff (100 %id) | |||
AW500507 | lymph | .b | 1025 to 1621 | 8 to 604 | 597/604 (98 %) | 0 diff (100 %id) | |||
AW500510 | lymph | .b | 1025 to 1565 | 8 to 548 | 541/548 (98 %) | 0 diff (100 %id) | |||
CF135599 | lymph | .a | 2522 to 2882 | 1 to 361 | 361/361 (100 %) | 4 diff (98.9 %id) | |||
CF138893 | lymph | .a | 2585 to 3080 | 1 to 496 | 496/496 (100 %) | 6 diff (98.8 %id) | |||
CF135223 | CNCAP(3)T-225 cell line, Prostate | .a | 4488 to 4992 | 1 to 505 | 505/505 (100 %) | 4 diff (99.3 %id) | |||
BF739801 | brain, oligodendroglioma | .a | 2611 to 3124 | 514 to 1 | 514/514 (100 %) | 1 diff (99.9 %id) | |||
BG702713 | brain, hippocampus | .b | 25 to 555 | 1 to 532 | 532/532 (100 %) | 8 diff (98.5 %id) | |||
BG718312 | testis | .b | 1 to 737 | 1 to 758 | 758/763 (99 %) | 35 diff (95.5 %id) | |||
BG765418 | melanotic melanoma, high MDR (cell line), skin | .d | 935 to 1249 | 1 to 318 | 318/622 (51 %) | 7 diff (98.9 %id) | |||
BI562454 | testis | .b | 27 to 863 | 1 to 842 | 842/851 (98 %) | 27 diff (96.9 %id) | |||
BQ720273 | sympathetic trunk | .a | 3091 to 3992 | 1 to 906 | 906/907 (99 %) | 13 diff (98.6 %id) | |||
CA848883 | Pancreas, Purified pancreatic islet | .d | 778 to 1267 | 491 to 1 | fully sequenced, | 491/491 (100 %) | 1 diff (99.8 %id) | ||
CA849187 | Pancreas, Purified pancreatic islet | .d | 480 to 808 | 1 to 329 | fully sequenced, | 329/329 (100 %) | 3 diff (99.1 %id) | ||
CA868150 | Pancreas, Purified pancreatic islet | .d | 480 to 892 | 1 to 413 | fully sequenced, | 413/413 (100 %) | 4 diff (99.1 %id) | ||
CA868391 | Pancreas, Purified pancreatic islet | .d | 862 to 1268 | 407 to 1 | fully sequenced, | 407/407 (100 %) | 2 diff (99.6 %id) | ||
CB962935 | Blood vessels - aorta, basilar and artery | .d | 732 to 1267 | 1 to 536 | 536/752 (71 %) | 3 diff (99.7 %id) | |||
CD516118 | White Matter | .d | 777 to 1679 | 29 to 944 | tiling clone, | 916/970 (94 %) | 27 diff (97.3 %id) | ||
CF122278 | CNCAP(3)T-225 cell line, Prostate | .a | 4533 to 5273 | 9 to 743 | 735/743 (98 %) | 6 diff (99.2 %id) | |||
CF122355 | CNCAP(3)T-225 cell line, Prostate | .a | 4533 to 4738 | 29 to 234 | 206/234 (88 %) | 6 diff (97.5 %id) | |||
TI_44350845 | .b | 30 to 863 | 83 to 921 | 839/930 (90 %) | 33 diff (96.5 %id) | ||||
DA658418 | .a | 2513 to 2928 | 2 to 417 | capped | 416/416 (100 %) | 0 diff (100 %id) | |||
DV462027 | cochlea, ear | .d | 647 to 1161 | 514 to 1 | Submitted on the opposite strand | 514/514 (100 %) | 5 diff (99.1 %id) | ||
NM_020940.3 | .a | 1 to 5802 | 1 to 5802 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 5802/5802 (100 %) | 0 diff (100 %id) | |
NM_001135051.1 | .b | 6 to 2869 | 1 to 2864 | RefSeq, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 2864/2864 (100 %) | 2 diff (100.0 %id) | ||
CK430989 | eye, lacrimal gland | .a | 3939 to 4548 | 1 to 610 | 610/613 (99 %) | 1 diff (99.9 %id) | |||
DA831318 | placenta | .a | 3631 to 4250 | 2 to 622 | capped | 621/621 (100 %) | 2 diff (99.7 %id) | ||
DB376943 | placenta | .a | 5257 to 5802 | 545 to 1 | 545/569 (95 %) | 14 diff (97.6 %id) | |||
DA832224 | placenta | .a | 4385 to 5141 | 2 to 765 | capped | 764/771 (99 %) | 16 diff (98.0 %id) | ||
DB378297 | placenta | .a | 5226 to 5802 | 576 to 1 | 576/599 (96 %) | 15 diff (97.5 %id) | |||
DA833205 | placenta | .a | 4234 to 5016 | 2 to 779 | capped | 778/781 (99 %) | 10 diff (98.8 %id) | ||
DB379818 | placenta | .a | 5016 to 5598 | 578 to 1 | 578/585 (98 %) | 17 diff (97.1 %id) | |||
CR999375 | T-Lymphocytes | .b | 9 to 513 | 1 to 506 | 506/508 (99 %) | 10 diff (98.1 %id) | |||
TI_1948141721 | .b | 341 to 1116 | 127 to 903 | 777/1353 (57 %) | 19 diff (98.6 %id) | ||||
TI_1948141724 | .b | 1578 to 2533 | 1107 to 152 | 956/1286 (74 %) | 31 diff (97.6 %id) | ||||
TI_1948142045 | .b | 341 to 1048 | 126 to 830 | 705/1312 (53 %) | 24 diff (98.2 %id) | ||||
TI_1948142046 | .b | 341 to 1144 | 123 to 933 | 811/1234 (65 %) | 32 diff (97.5 %id) | ||||
TI_1948142047 | .b | 1797 to 2533 | 888 to 145 | 744/1459 (50 %) | 24 diff (98.4 %id) | ||||
TI_1948142048 | .b | 1728 to 2533 | 949 to 148 | 802/1393 (57 %) | 16 diff (98.9 %id) | ||||
TI_1948142381 | .b | 341 to 1140 | 132 to 931 | 800/1326 (60 %) | 41 diff (97.0 %id) | ||||
TI_1948142382 | .b | 341 to 1090 | 128 to 882 | 755/1235 (61 %) | 21 diff (98.3 %id) | ||||
TI_1948142383 | .b | 1617 to 2533 | 1061 to 148 | 914/1349 (67 %) | 35 diff (97.5 %id) | ||||
TI_1948142384 | .b | 1665 to 2533 | 1029 to 160 | 870/1325 (65 %) | 24 diff (98.2 %id) | ||||
TI_1948142718 | .b | 341 to 1121 | 133 to 912 | 780/1361 (57 %) | 29 diff (97.9 %id) | ||||
TI_1948142719 | .b | 386 to 1140 | 166 to 927 | 762/1217 (62 %) | 37 diff (97.0 %id) | ||||
DA902360 | .a | 3324 to 3903 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | |||
DB048925 | testis | .b | 992 to 1545 | 2 to 555 | capped | 554/555 (99 %) | 0 diff (100 %id) | ||
DB054254 | testis | .b | 1377 to 1945 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 0 diff (100 %id) | ||
DB109194 | thymus | .a | 3893 to 4467 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | ||
DB135752 | thymus | .a | 2833 to 3394 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
DB146636 | thymus | .a | 2180 to 2804 | 2 to 627 | capped | 626/626 (100 %) | 3 diff (99.6 %id) | ||
TI_149282437 | .d | 232 to 1264 | 1111 to 84 | AAA | 1028/1190 (86 %) | 49 diff (95.9 %id) | |||
TI_149299049 | .d | 310 to 1268 | 1032 to 89 | AAA | 944/982 (96 %) | 22 diff (97.8 %id) | |||
TI_149299968 | .d | 606 to 1264 | 747 to 89 | AAA | 659/660 (99 %) | 0 diff (100 %id) | |||
TI_154154741 | .b | 1025 to 1645 | 80 to 699 | 620/628 (98 %) | 4 diff (99.4 %id) | ||||
TI_154154782 | .b | 1025 to 1663 | 81 to 719 | 639/639 (100 %) | 1 diff (99.9 %id) | ||||
TI_154163405 | .a | 4496 to 5144 | 81 to 734 | 654/849 (77 %) | 15 diff (98.3 %id) | ||||
TI_154169027 | .a | 2591 to 3103 | 77 to 589 | 513/514 (99 %) | 2 diff (99.7 %id) | ||||
TI_154181800 | .a | 4533 to 5340 | 71 to 862 | 792/911 (86 %) | 16 diff (98.3 %id) | ||||
TI_157613606 | .d | 695 to 1264 | 659 to 90 | AAA | 570/570 (100 %) | 1 diff (99.9 %id) | |||
CF528131 | placenta | .d | 715 to 1264 | 567 to 18 | AAA | 550/550 (100 %) | 1 diff (99.9 %id) | ||
BU674632 | lung, Primary Lung Epithelial Cells | .a | 4722 to 5001 | 1 to 280 | AAA | Submitted on the opposite strand | 280/280 (100 %) | 2 diff (99.3 %id) | |
BM983851 | lung, Primary Lung Epithelial Cells | .d | 544 to 1264 | 740 to 19 | AAA | 722/722 (100 %) | 2 diff (99.8 %id) | ||
BM975535 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 546 to 1268 | 737 to 15 | AAA | 723/723 (100 %) | 0 diff (100 %id) | ||
BM976143 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 626 to 1264 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
BU609204 | Human Lung Epithelial cells, lung | .a | 3905 to 4310 | 338 to 743 | Submitted on the opposite strand | 406/743 (54 %) | 6 diff (99.2 %id) | ||
CA311318 | Human Lung Epithelial cells, lung | .a | 4535 to 5001 | 486 to 20 | AAA | 467/472 (98 %) | 2 diff (99.6 %id) | ||
BM662684 | eye, RPE and Choroid | .a | 2608 to 3117 | 527 to 18 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 510/510 (100 %) | 0 diff (100 %id) | |
BM699942 | eye, lens | .a | 2338 to 2820 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
BM674102 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1058 to 1264 | 1 to 207 | AAA | Submitted on the opposite strand | 207/207 (100 %) | 7 diff (96.7 %id) | |
BM715749 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1064 to 1264 | 230 to 30 | AAA | Submitted on the opposite strand | 201/212 (94 %) | 2 diff (99.1 %id) | |
BM718550 | eye, fetal eye | .d | 228 to 752 | 1 to 525 | 525/525 (100 %) | 0 diff (100 %id) | |||
BQ574802 | Chondrosarcoma Grade II, Left Pelvis | .d | 799 to 1264 | 484 to 19 | AAA | 466/466 (100 %) | 0 diff (100 %id) | ||
CA430203 | cell lines, Chondrosarcoma | .d | 579 to 1264 | 702 to 19 | AAA | 684/684 (100 %) | 2 diff (99.8 %id) | ||
BU634066 | cell lines, Chondrosarcoma | .a | 2580 to 3186 | 624 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 606/606 (100 %) | 1 diff (99.9 %id) | |
TI_153949440 | .a | 2388 to 3079 | 77 to 776 | 700/1048 (66 %) | 19 diff (98.2 %id) | ||||
TI_151716288 | .a | 2837 to 3501 | 824 to 156 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 669/943 (70 %) | 0 diff (100 %id) | ||
TI_151777302 | .d | 1064 to 1264 | 333 to 133 | AAA | Submitted on the opposite strand | 201/1411 (14 %) | 2 diff (99.9 %id) | ||
TI_151760621 | .d | 488 to 1268 | 861 to 85 | AAA | 777/929 (83 %) | 6 diff (99.4 %id) | |||
DB282706 | uterus | .b | 1886 to 2435 | 2 to 553 | capped | 552/552 (100 %) | 2 diff (99.7 %id) | ||
AL833226 | lymph node | .a | 3893 to 4467 | 2 to 577 | available from DKFZ, AAA | Suspected internal deletion, this clone was ignored | 576/576 (100 %) | 1 diff (99.9 %id) | |
DB507339 | testis | .a | 2833 to 3394 | 2 to 563 | Submitted on the opposite strand | 562/562 (100 %) | 0 diff (100 %id) | ||
BQ880541 | brain, neuroblastoma, cell line | .a | 2180 to 2804 | 2 to 627 | 626/626 (100 %) | 3 diff (99.6 %id) | |||
TI_149282437 | .d | 232 to 1264 | 1111 to 84 | AAA | 1028/1190 (86 %) | 49 diff (95.9 %id) | |||
TI_149299049 | .d | 310 to 1268 | 1032 to 89 | AAA | 944/982 (96 %) | 22 diff (97.8 %id) | |||
TI_149299968 | .d | 606 to 1264 | 747 to 89 | AAA | 659/660 (99 %) | 0 diff (100 %id) | |||
TI_154154741 | .b | 1025 to 1645 | 80 to 699 | 620/628 (98 %) | 4 diff (99.4 %id) | ||||
TI_154154782 | .b | 1025 to 1663 | 81 to 719 | 639/639 (100 %) | 1 diff (99.9 %id) | ||||
TI_154163405 | .a | 4496 to 5144 | 81 to 734 | 654/849 (77 %) | 15 diff (98.3 %id) | ||||
TI_154169027 | .a | 2591 to 3103 | 77 to 589 | 513/514 (99 %) | 2 diff (99.7 %id) | ||||
TI_154181800 | .a | 4533 to 5340 | 71 to 862 | 792/911 (86 %) | 16 diff (98.3 %id) | ||||
TI_157613606 | .d | 695 to 1264 | 659 to 90 | AAA | 570/570 (100 %) | 1 diff (99.9 %id) | |||
CF528131 | placenta | .d | 715 to 1264 | 567 to 18 | AAA | 550/550 (100 %) | 1 diff (99.9 %id) | ||
BU674632 | lung, Primary Lung Epithelial Cells | .a | 4722 to 5001 | 1 to 280 | AAA | Submitted on the opposite strand | 280/280 (100 %) | 2 diff (99.3 %id) | |
BU674632 | lung, Primary Lung Epithelial Cells | .a | 4722 to 5001 | 1 to 280 | AAA | Submitted on the opposite strand | 280/280 (100 %) | 2 diff (99.3 %id) | |
BM983851 | lung, Primary Lung Epithelial Cells | .d | 544 to 1264 | 740 to 19 | AAA | 722/722 (100 %) | 2 diff (99.8 %id) | ||
BM983851 | lung, Primary Lung Epithelial Cells | .d | 544 to 1264 | 740 to 19 | AAA | 722/722 (100 %) | 2 diff (99.8 %id) | ||
BM975535 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 546 to 1268 | 737 to 15 | AAA | 723/723 (100 %) | 0 diff (100 %id) | ||
BM975535 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 546 to 1268 | 737 to 15 | AAA | 723/723 (100 %) | 0 diff (100 %id) | ||
BM976143 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 626 to 1264 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
BM976143 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .d | 626 to 1264 | 657 to 19 | AAA | 639/639 (100 %) | 0 diff (100 %id) | ||
BU609204 | Human Lung Epithelial cells, lung | .a | 3905 to 4310 | 338 to 743 | Submitted on the opposite strand | 406/743 (54 %) | 6 diff (99.2 %id) | ||
BU609204 | Human Lung Epithelial cells, lung | .a | 3905 to 4310 | 338 to 743 | Submitted on the opposite strand | 406/743 (54 %) | 6 diff (99.2 %id) | ||
CA311318 | Human Lung Epithelial cells, lung | .a | 4535 to 5001 | 486 to 20 | AAA | 467/472 (98 %) | 2 diff (99.6 %id) | ||
CA311318 | Human Lung Epithelial cells, lung | .a | 4535 to 5001 | 486 to 20 | AAA | 467/472 (98 %) | 2 diff (99.6 %id) | ||
BM662684 | eye, RPE and Choroid | .a | 2608 to 3117 | 527 to 18 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 510/510 (100 %) | 0 diff (100 %id) | |
BM662684 | eye, RPE and Choroid | .a | 2608 to 3117 | 527 to 18 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 510/510 (100 %) | 0 diff (100 %id) | |
BM699942 | eye, lens | .a | 2338 to 2820 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
BM699942 | eye, lens | .a | 2338 to 2820 | 1 to 483 | 483/483 (100 %) | 0 diff (100 %id) | |||
BM674102 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1058 to 1264 | 1 to 207 | AAA | Submitted on the opposite strand | 207/207 (100 %) | 7 diff (96.7 %id) | |
BM674102 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1058 to 1264 | 1 to 207 | AAA | Submitted on the opposite strand | 207/207 (100 %) | 7 diff (96.7 %id) | |
BM715749 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1064 to 1264 | 230 to 30 | AAA | Submitted on the opposite strand | 201/212 (94 %) | 2 diff (99.1 %id) | |
BM715749 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .d | 1064 to 1264 | 230 to 30 | AAA | Submitted on the opposite strand | 201/212 (94 %) | 2 diff (99.1 %id) | |
BM718550 | eye, fetal eye | .d | 228 to 752 | 1 to 525 | 525/525 (100 %) | 0 diff (100 %id) | |||
BM718550 | eye, fetal eye | .d | 228 to 752 | 1 to 525 | 525/525 (100 %) | 0 diff (100 %id) | |||
BQ574802 | Chondrosarcoma Grade II, Left Pelvis | .d | 799 to 1264 | 484 to 19 | AAA | 466/466 (100 %) | 0 diff (100 %id) | ||
BQ574802 | Chondrosarcoma Grade II, Left Pelvis | .d | 799 to 1264 | 484 to 19 | AAA | 466/466 (100 %) | 0 diff (100 %id) | ||
CA430203 | cell lines, Chondrosarcoma | .d | 579 to 1264 | 702 to 19 | AAA | 684/684 (100 %) | 2 diff (99.8 %id) | ||
CA430203 | cell lines, Chondrosarcoma | .d | 579 to 1264 | 702 to 19 | AAA | 684/684 (100 %) | 2 diff (99.8 %id) | ||
BU634066 | cell lines, Chondrosarcoma | .a | 2580 to 3186 | 624 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 606/606 (100 %) | 1 diff (99.9 %id) | |
BU634066 | cell lines, Chondrosarcoma | .a | 2580 to 3186 | 624 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 606/606 (100 %) | 1 diff (99.9 %id) | |
TI_153949440 | .a | 2388 to 3079 | 77 to 776 | 700/1048 (66 %) | 19 diff (98.2 %id) | ||||
TI_151716288 | .a | 2837 to 3501 | 824 to 156 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 669/943 (70 %) | 0 diff (100 %id) | ||
TI_151777302 | .d | 1064 to 1264 | 333 to 133 | AAA | Submitted on the opposite strand | 201/1411 (14 %) | 2 diff (99.9 %id) | ||
TI_151760621 | .d | 488 to 1268 | 861 to 85 | AAA | 777/929 (83 %) | 6 diff (99.4 %id) | |||
DB282706 | uterus | .b | 1886 to 2435 | 2 to 553 | capped | 552/552 (100 %) | 2 diff (99.7 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e-u, .f | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes C |